By multivariate analysis before treatment, an allelic imbalance of TP73 was the most useful independent predictive factor in predicting cause-specific survival in bladder cancer patients treated by CRT (Table 5, P=0.0002, Risk ratio: 3382). Here, TP73 is linked to urinary bladder carcinoma.